The Global Cell Isolation/Cell Separation Market is expected to grow from USD 6,356.88 Million in 2019 to USD 14,485.68 Million by the end of 2025 at…

Market Segmentation & Coverage: This research report categorizes the Cell Isolation/Cell Separation to forecast the revenues and analyze the trends in each of the following sub-markets:

New York, June 19, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Isolation/Cell Separation Market Research Report by Product, by Cell Type, by Cell Source, by Technique, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05913776/?utm_source=GNW

On the basis of Product, the Cell Isolation/Cell Separation Market is studied across Consumables and Instruments. The Consumables further studied across Beads, Disposables, and Reagents, Kits, Media, and Sera. The Instruments further studied across Centrifuges, Filtration Systems, Flow Cytometers, and Magnetic-Activated Cell Separator Systems.

On the basis of Cell Type, the Cell Isolation/Cell Separation Market is studied across Animal Cells and Human Cells. The Human Cells further studied across Differentiated Cells and Stem Cells.

On the basis of Cell Source, the Cell Isolation/Cell Separation Market is studied across Adipose Tissue, Bone Marrow, and Cord Blood/Embryonic Stem Cells.

On the basis of Technique, the Cell Isolation/Cell Separation Market is studied across Centrifugation-Based Cell Isolation, Filtration-Based Cell Isolation, and Surface Marker-Based Cell Isolation.

On the basis of Application, the Cell Isolation/Cell Separation Market is studied across Biomolecule Isolation, Cancer Research, In Vitro Diagnostics, Stem Cell Research, and Tissue Regeneration & Regenerative Medicine.

On the basis of End User, the Cell Isolation/Cell Separation Market is studied across Biotechnology & Biopharmaceutical Companies, Hospitals & Diagnostic Laboratories, and Research Laboratories & Institutes.

On the basis of Geography, the Cell Isolation/Cell Separation Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Isolation/Cell Separation Market including Beckman Coulter Inc. (Subsidiary of Danaher Corporation), Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., GE Healthcare, Merck KGaA, Miltenyi Biotec, Pluriselect Life Science Ug (Haftungsbeschrnkt) & Co. Kg, Stemcell Technologies, Inc., Terumo Bct, and Thermo Fisher Scientific, Inc..

FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Isolation/Cell Separation Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as: 1. What is the market size and forecast of the Global Cell Isolation/Cell Separation Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Isolation/Cell Separation Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Isolation/Cell Separation Market? 4. What is the competitive strategic window for opportunities in the Global Cell Isolation/Cell Separation Market? 5. What are the technology trends and regulatory frameworks in the Global Cell Isolation/Cell Separation Market? 6. What are the modes and strategic moves considered suitable for entering the Global Cell Isolation/Cell Separation Market? Read the full report: https://www.reportlinker.com/p05913776/?utm_source=GNW

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Go here to read the rest:
The Global Cell Isolation/Cell Separation Market is expected to grow from USD 6,356.88 Million in 2019 to USD 14,485.68 Million by the end of 2025 at...

Impact of COVID-19 on Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2020 Key Players, Opportunities, Challenges, Trend and Forecast by…

Notice:This Content doesnt contains all the Information of the Report please fill the form (via link) and get all interesting information just one click in PDF with latest update with chart and Table of Content

The report offers a systematic presentation of the existing trends, growth opportunities, market dynamics that are expected to shape the growth of the Autologous Stem Cell and Non-Stem Cell Based Therapies market. The various research methods and tools were involved in the market analysis, to uncover crucial information about the market such as current & future trends, opportunities, business strategies and more, which in turn will aid the business decision-makers to make the right decision in future.

This Report Covers Leading Companies Associated in Worldwide Autologous Stem Cell and Non-Stem Cell Based Therapies Market: Caladrius Biosciences, Vericel Corporation, Fibrocell Science, Inc., Genzyme Corporation, BrainStorm Cell Therapeutics, Regeneus Ltd., and Dendreon Corporation.

We Do Offer Sample of this report. Kindly go through the follow information in order to access sample copy.

Note- This report sample includes:

Brief Introduction to the research report.

Table of Contents (Scope covered as a part of the study)

Top players in the market

Research framework (Structure Of The Report)

Research methodology adopted by Coherent Market Insights

Request Sample Copy of this Report: https://www.coherentmarketinsights.com/insight/request-sample/523

The report begins with a brief introduction and market overview of the Autologous Stem Cell and Non-Stem Cell Based Therapies industry followed by its market scope and size. Next, the report provides an overview of market segmentation such as type, application, and region. The drivers, limitations, and opportunities for the market are also listed along with current trends and policies in the industry.

The key players profiled in this report include: Caladrius Biosciences, Vericel Corporation, Fibrocell Science, Inc., Genzyme Corporation, BrainStorm Cell Therapeutics, Regeneus Ltd., and Dendreon Corporation.

Regions included:

o North America (United States, Canada, and Mexico)

o Europe (Germany, France, UK, Russia, and Italy)

o Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

o South America (Brazil, Argentina, Colombia)

o Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

The PDF Research only provides Table of Contents (ToC), scope of the report and research framework of the report.

Get a PDF Brochure of this Report: https://www.coherentmarketinsights.com/insight/request-pdf/523

Key Benefits:

o This study gives a detailed analysis of drivers and factors limiting the market expansion of Autologous Stem Cell and Non-Stem Cell Based Therapies

o The micro-level analysis is conducted based on its product types, end-user applications, and geographies

o Porters five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players

o By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Autologous Stem Cell and Non-Stem Cell Based Therapies market

The research study can answer the following Key questions:

Table of Contents

Report Overview: It includes the Autologous Stem Cell and Non-Stem Cell Based Therapies market study scope, players covered, key market segments, market analysis by application, market analysis by type, and other chapters that give an overview of the research study.

Executive Summary: This section of the report gives information about Autologous Stem Cell and Non-Stem Cell Based Therapies market trends and shares, market size analysis by region and analysis of global market size. Under market size analysis by region, analysis of market share and growth rate by region is provided.

Profiles of International Players: Here, key players of the Autologous Stem Cell and Non-Stem Cell Based Therapies market are studied on the basis of gross margin, price, revenue, corporate sales, and production. This section gives a business overview of the players and shares their important company details.

Regional Study: All of the regions and countries analyzed in the Autologous Stem Cell and Non-Stem Cell Based Therapies market report is studied on the basis of market size by application, the market size by product, key players, and market forecast.

Get Offer on Report: https://www.coherentmarketinsights.com/insight/request-discount/523

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, LATAM, West Europe, MENA Countries, Southeast Asia or Asia Pacific.

About Us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us: Coherent Market Insights, 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Email: sales@coherentmarketinsights.com Phone: US +1-206-701-6702/UK +44-020 8133 4027

Read the original post:
Impact of COVID-19 on Autologous Stem Cell and Non-Stem Cell Based Therapies Market 2020 Key Players, Opportunities, Challenges, Trend and Forecast by...

Global trade impact of the Coronavirus Canine Stem Cell Therapy Market Research Insights 2019 Global Industry Outlook Shared in Detailed Report,…

The recent outbreak of the COVID-19 (Coronavirus) pandemic has built and broken many value-grab opportunities for companies in the Canine Stem Cell Therapy market. Gain full access on our latest analysis about COVID-19 and how companies in the Canine Stem Cell Therapy market are capitalizing on new strategies to maintain stable revenue income. Look into our resourceful insights highlighting the impact of COVID-19 caused on the global market landscape.

Why Choose MRRSE Research?

Request Sample Report @https://www.mrrse.com/sample/16152?source=atm

The report on the global Canine Stem Cell Therapy market published by Market Research Reports Search Engine(MRRSE) provides a clear understanding of the flight of the Canine Stem Cell Therapy market over the forecast period (20XX-20XX). The study introspects the various factors that are tipped to influence the growth of the Canine Stem Cell Therapy market in the upcoming years. The current trends, growth opportunities, restraints, and major challenges faced by market players in the Canine Stem Cell Therapy market are analyzed in the report.

The study reveals that the global Canine Stem Cell Therapy market is projected to reach a market value of ~US$XX by the end of 20XX and grow at a CAGR of ~XX% during the assessment period. Further, a qualitative and quantitative analysis of the Canine Stem Cell Therapy market based on data collected from various credible sources in the market value chain is included in the report along with relevant tables, graphs, and figures.

Request For Discount On This Report @ https://www.mrrse.com/checkdiscount/16152?source=atm

Key Takeaways of the Report:

Canine Stem Cell Therapy Market Segmentation

By Region

The presented study throws light on the current and future prospects of the Canine Stem Cell Therapy market in various geographies such as:

By Product Type

The report highlights the product adoption pattern of various products in the Canine Stem Cell Therapy market and provides intricate insights such as the consumption volume, supply-demand ratio, and pricing models of the following products:

Market Taxonomy

The global canine stem cell therapy market has been segmented into:

Product Type:

Application:

End User:

Region:

Buy This Report @ https://www.mrrse.com/checkout/16152?source=atm

The report addresses the following doubts related to the Canine Stem Cell Therapy market:

View post:
Global trade impact of the Coronavirus Canine Stem Cell Therapy Market Research Insights 2019 Global Industry Outlook Shared in Detailed Report,...

Regenerative Medicine Market to Record a Robust Growth Rate for the COVID-19 Period – Cole of Duty

Overview: Regenerative medicine is an interdisciplinary field that applies life science and engineering principles for the regeneration or repair of injured/diseased tissues or organs resulting from various causes including, disease, defects, trauma and aging. The field includes the generation and use of tissue engineering, therapeutic stem cells and the production of artificial organs. It also allows scientists to grow organs or tissues in the lab and implant them in the body safely when the body fails to heal itself. Notably, it has great potential to solve the problem of organ shortage.

Request For Report [emailprotected]https://www.trendsmarketresearch.com/report/sample/9918

According to the estimation of World Health Organization, there is an increasing prevalence of diabetes among adults over the age of 18 years, that has increased to 8.5% in 2014 compared to 4.5% in 1980 across the globe. As per the estimation of Arthritis Foundation, the number of people expected to be diagnosed from arthritis will be more than 78 million, by 2040.

The market for regenerative medicine is driven by increasing prevalence of neuronal disease, cancer and genetic disease, emerging application of regenerative medicine, and advancement in technology. Huge number of ongoing clinical trails and strong product pipeline are providing market growth oppurtunity. High cost of the treatment, regulatory issues and ethical issuesare hampering the market growth.

Market Analysis: The Global Regenerative Medicine market is estimated to witness a CAGR of 16.6% during the forecast period 20182024. The global market is analyzed based on three segments Therapy, Application and regions.

Regional Analysis: The regions covered in the report are the North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is the major shareholder in the global regenerative medicine market, followed by Europe. Asia-Pacific region is expected to have the fastest growth rate with the market growth centered at Japan, China and India. This is mainly due to increasing funding in healthcare research, rising research activities, growing patient pool, flexible regulatory environment for clinical trials, and rising healthcare expenditure.

Get Complete TOC with Tables and [emailprotected]https://www.trendsmarketresearch.com/report/discount/9918

Therapy Analysis:Immunotherapy occupied major market share of global regenerative medicine market in 2017, and is expected to remain same during the forecasted period. Increasing product approvals, emerging technological advancements in cell and gene therapy, flexible regulatory for stem cell based research, and growing awareness regarding the benefits of stem cell therapies.

Application Analysis: The market by application is segmented into cancer, central nervous system, orthopedic and musculoskeletal, diabetes, dermatology, cardiovascular and others. Among various application, dermatology occupied the largest share in 2017 and cancer segment is expected to grow at fastest rate during the forecasted period. Growing aging population, changing lifestyle, increasing disease prevalence makes cancer, the fastest growing application segment during the forecasted period.

Key Players: Allergan plc, Integra lifesciences, Mimedx Group, Inc., Medtronic plc, Organogenesis Inc., Zimmer Biomet, Acelity L.P. Inc., Nuvasive, Inc., Stryker Corporation, Japan Tissue Engineering Co., Ltd. (Fujifilm Holdings Corporation subsidiary), Osiris Therapeutics, Inc., Vericel Corporationand other predominate and niche players.

Competitive Analysis: Currently dermatology segment dominates the global regenerative medicine segment. A lot of researches are going on cancer, CNS, cardiovascular, orthopedic & musculoskeletal applications. The increasing importance of regenerative medicine has resulted in the launch of new products and also increased acquisition, approvals, funding to develop new product.

For instance, in August 2017, Tissue Regenix Group plc completed the acquisition of acquisition of CellRight Technologies, an US based specialist in regenerative osteoinductive bone scaffolds. In April 2018, Roche acquired a program named Inception 5, focused on regenerative therapies for multiple sclerosis. In May 2018, Novartis received second FDA approval for Kymriah, CAR-T cell therapy for B-cell acute lymphoblastic leukemia (ALL)

<<< Get COVID-19 Report Analysis >>>https://www.trendsmarketresearch.com/report/covid-19-analysis/9918

Benefits: The report provides complete details about the usage and adoption rate of regenerative medicine in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical players initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

See the original post here:
Regenerative Medicine Market to Record a Robust Growth Rate for the COVID-19 Period - Cole of Duty

Scientists Finally Know Where Thorns Come From – Daily Times

Why do plants have thorns? is an easy question: The thorns help protect against hungry animals that like to munch on the plants. Where do thorns come from? is a more complicated questionbut Yale scientists have found an answer.

The insight, reported on the June 18 issue of Current Biology, may help change the way oranges and other crops are grown.

First, a primer for non-botanists: Many plants have sharp, spiky armor that can be classified as thorns, prickles or spines.

Rose bushes do not have thorns; they have prickles, as do raspberry and blackberry bushes. Prickles are like thick hairs on your arm, and in roses and other prickly plants, the prickles grow from their epidermis, or skin, said Vivian Irish, chair and the Eaton Professor of Molecular, Cellular and Developmental Biology and senior author of the study.

Other plants, including cacti, have spines, another type of sharp, pointy weaponry that forms instead of leaves. Thorns arise from shoots in plants such as bougainvillea, hawthorn and citrus.

Irish, who is also professor of ecology and evolutionary biology, was fascinated by thorns that grow on old honey locust trees, commonly found along the streets of New Haven and other urban areas. While most honey locusts have been bred so that they no longer have thorns, some older trees with dangerous, foot-long thorns still exist. As a plant scientist, she was intrigued by how these structures arose, but she put off investigating the question for decades.

As it happens, she is also an expert on stem cells. And as it turns out, stem cells can explain thorns.

Irish and her research team first showed that, in citrus plants, thorns arise from the plants stem cell populations. Unlike typical stem cells in animals or plants, which continue to divide, thorn stem cells undergo a programmed arrest. The scientists found that two regulators of stem cell production, TI1 and TI2, gradually shut down stem cell activity in the developing thorn, so that it tapers off until nothing is left but the sharp pointy end.

When the researchers genetically eliminated the two regulators, stem cell activity continued, and instead of thorns, the citrus plants produced new branches.

The insight could lead to orchards of orange trees with more fruit-bearing branches ones that pose less danger to laborers who pick the fruit, Irish said.

The rest is here:
Scientists Finally Know Where Thorns Come From - Daily Times

The Global Cell Separation Technologies Market is expected to grow from USD 5,347.52 Million in 2019 to USD 12,724.42 Million by the end of 2025 at a…

June 19, 2020 00:32 ET | Source: ReportLinker

New York, June 19, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell Separation Technologies Market Research Report by Technology, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05913778/?utm_source=GNW

On the basis of Technology, the Cell Separation Technologies Market is studied across Fluorescence-activated Cell Sorting, Immunomagnetic Cell Separation, and Microfluidic Cell Separation.

On the basis of Application, the Cell Separation Technologies Market is studied across Cancer Research, Immunology, and Stem Cell Research.

On the basis of End User, the Cell Separation Technologies Market is studied across Biotechnology and Pharmaceutical Companies and Hospitals and Diagnostic Laboratories.

On the basis of Geography, the Cell Separation Technologies Market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region is studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region is studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region is studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Cell Separation Technologies Market including BD Biosciences, Life Technologies Corporation, Merck Millipore, Miltenyi Biotec GmbH, STEMCELL Technologies, Inc., and Terumo BCT, Inc..

FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Separation Technologies Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as: 1. What is the market size and forecast of the Global Cell Separation Technologies Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cell Separation Technologies Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cell Separation Technologies Market? 4. What is the competitive strategic window for opportunities in the Global Cell Separation Technologies Market? 5. What are the technology trends and regulatory frameworks in the Global Cell Separation Technologies Market? 6. What are the modes and strategic moves considered suitable for entering the Global Cell Separation Technologies Market? Read the full report: https://www.reportlinker.com/p05913778/?utm_source=GNW

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

See the rest here:
The Global Cell Separation Technologies Market is expected to grow from USD 5,347.52 Million in 2019 to USD 12,724.42 Million by the end of 2025 at a...

Cell Separation Technologies Market Analysis with Research Report 2020 – Cole of Duty

The Cell Separation Technologies Market report is a collection of pragmatic information, quantitative and qualitative estimation by industry experts, the contribution from industry connoisseurs and industry accomplices across the value chain. Furthermore, the report also provides the qualitative results of diverse market factors on its geographies and segments.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Get sample copy of this report before purchase at:

https://www.marketinsightsreports.com/reports/05182019198/covid-19-impact-on-cell-separation-technologies-market-global-research-reports-2020-2021/inquiry?Mode=RJ

Mitenyi Biotec GmbH, BD Bioscience, STEMCELL Technologies Terumo BCT, pluriSelect GmbH, EMD Millipore, Life Technologies, and other.

Cell Separation Technologies Global Market Report from Market Insights Reports covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market. The market characteristics section of the report defines and explains the market. The market size section gives the market revenues, covering both the historic growth of the market and forecasting the future. Drivers and restraints look at the external factors influencing the growth of the market. Market segmentations break down the key sub sectors which make up the market.

Gradient Centrifugation

Surface Markers Separation

Fluorescence Activated Cell Sorting

Magnetic Cell Sorting

Others

Market segment by Application

Oncology Research

Neuroscience Research

Stem Cell Research

Microbiology and Immunology Research

Others

Get full access to this report at:

https://www.marketinsightsreports.com/reports/05182019198/covid-19-impact-on-cell-separation-technologies-market-global-research-reports-2020-2021?Mode=RJ

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last five years are identified. The trends and strategies section highlights the likely future developments in the market and suggests approaches.

The research includes historic data from 2015 to 2019 and forecasts until 2021 which makes the reports an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

How we have factored the effect of Covid-19 in our report:

All the reports that we list have been tracking the impact of COVID-19. Both upstream and downstream of the entire supply chain has been accounted for while doing this. Also, where possible, we will provide an additional COVID-19 update supplement/report to the report in Q3, please check for with the sales team.

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact US:

Irfan Tamboli (Head of Sales)

Market Insights Reports

Phone: + 1704 266 3234 | Mob: +91-750-707-8687

[emailprotected] | [emailprotected]

See the article here:
Cell Separation Technologies Market Analysis with Research Report 2020 - Cole of Duty

Stem Cell Antibody Market Research Report: Probable Key Development To Be Observed Market States And Outlook Across By 2026 – Bulletin Line

Los Angeles, United State: Complete study of the global Stem Cell Antibody market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Stem Cell Antibody industry. Research techniques like PESTLE and Porters Five Forces analysis have been deployed by the researchers. They have also provided accurate data on Stem Cell Antibody production, capacity, price, cost, margin, and revenue to help the players gain a clear understanding into the overall existing and future market situation.

The research study includes great insights about critical market dynamics, including drivers, restraints, trends, and opportunities. It also includes various types of market analysis such as competitive analysis, manufacturing cost analysis, manufacturing process analysis, price analysis, and analysis of market influence factors. It is a complete study on the global Stem Cell Antibody market that can be used as a set of effective guidelines for ensuring strong growth in the coming years. It caters to all types of interested parties, viz. stakeholders, market participants, investors, market researchers, and other individuals associated with the Stem Cell Antibody business.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart)https://www.qyresearch.com/sample-form/form/947677/global-stem-cell-antibody-market

It is important for every market participant to be familiar with the competitive scenario in the global Stem Cell Antibody industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key Players Mentioned in the Global Stem Cell Antibody Market Research Report: , Thermo Fisher Scientific, Inc. (U.S.), Merck Group (Germany), Abcam plc (U.K.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Danaher Corporation (U.S.), GenScript (U.S.), PerkinElmer, Inc. (U.S.), Lonza (Switzerland), and BioLegend, Inc. (U.S.)

Global Stem Cell Antibody Market Segmentation by Product: Primary Antibodies, Secondary Antibodies

Global Stem Cell Antibody Market Segmentation by Application: , Proteomics, Drug Development, Genomics

The report has classified the global Stem Cell Antibody industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Stem Cell Antibody manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Stem Cell Antibody industry.

Additionally, the industry analysts have studied key regions including North America, Europe, Asia Pacific, Latin America, and Middle East and Africa, along with their respective countries. Here, they have given a clear-cut understanding of the present and future situations of the global Stem Cell Antibody industry in key regions. This will help the key players to focus on the lucrative regional markets.

Key questions answered in the report:

Request for customization in Report:https://www.qyresearch.com/customize-request/form/947677/global-stem-cell-antibody-market

Table of Content

Table of Contents Executive Summary 1 Stem Cell Antibody Market Overview 1.1 Product Overview and Scope of Stem Cell Antibody 1.2 Stem Cell Antibody Segment by Type 1.2.1 Global Stem Cell Antibody Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Primary Antibodies 1.2.3 Secondary Antibodies 1.3 Stem Cell Antibody Segment by Application 1.3.1 Stem Cell Antibody Consumption Comparison by Application (2014-2025) 1.3.2 Proteomics 1.3.3 Drug Development 1.3.4 Genomics 1.3 Global Stem Cell Antibody Market by Region 1.3.1 Global Stem Cell Antibody Market Size Region 1.3.2 North America Status and Prospect (2014-2025) 1.3.3 Europe Status and Prospect (2014-2025) 1.3.4 China Status and Prospect (2014-2025) 1.3.5 Japan Status and Prospect (2014-2025) 1.3.6 Southeast Asia Status and Prospect (2014-2025) 1.3.7 India Status and Prospect (2014-2025) 1.4 Global Stem Cell Antibody Market Size 1.4.1 Global Stem Cell Antibody Revenue (2014-2025) 1.4.2 Global Stem Cell Antibody Production (2014-2025) 2 Global Stem Cell Antibody Market Competition by Manufacturers 2.1 Global Stem Cell Antibody Production Market Share by Manufacturers (2014-2019) 2.2 Global Stem Cell Antibody Revenue Share by Manufacturers (2014-2019) 2.3 Global Stem Cell Antibody Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Stem Cell Antibody Production Sites, Area Served, Product Types 2.5 Stem Cell Antibody Market Competitive Situation and Trends 2.5.1 Stem Cell Antibody Market Concentration Rate 2.5.2 Stem Cell Antibody Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Stem Cell Antibody Production Market Share by Regions 3.1 Global Stem Cell Antibody Production Market Share by Regions 3.2 Global Stem Cell Antibody Revenue Market Share by Regions (2014-2019) 3.3 Global Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Stem Cell Antibody Production 3.4.1 North America Stem Cell Antibody Production Growth Rate (2014-2019) 3.4.2 North America Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 3.5 Europe Stem Cell Antibody Production 3.5.1 Europe Stem Cell Antibody Production Growth Rate (2014-2019) 3.5.2 Europe Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 3.6 China Stem Cell Antibody Production (2014-2019) 3.6.1 China Stem Cell Antibody Production Growth Rate (2014-2019) 3.6.2 China Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 3.7 Japan Stem Cell Antibody Production (2014-2019) 3.7.1 Japan Stem Cell Antibody Production Growth Rate (2014-2019) 3.7.2 Japan Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 4 Global Stem Cell Antibody Consumption by Regions 4.1 Global Stem Cell Antibody Consumption by Regions 4.2 North America Stem Cell Antibody Consumption (2014-2019) 4.3 Europe Stem Cell Antibody Consumption (2014-2019) 4.4 China Stem Cell Antibody Consumption (2014-2019) 4.5 Japan Stem Cell Antibody Consumption (2014-2019) 5 Global Stem Cell Antibody Production, Revenue, Price Trend by Type 5.1 Global Stem Cell Antibody Production Market Share by Type (2014-2019) 5.2 Global Stem Cell Antibody Revenue Market Share by Type (2014-2019) 5.3 Global Stem Cell Antibody Price by Type (2014-2019) 5.4 Global Stem Cell Antibody Production Growth by Type (2014-2019) 6 Global Stem Cell Antibody Market Analysis by Applications 6.1 Global Stem Cell Antibody Consumption Market Share by Application (2014-2019) 6.2 Global Stem Cell Antibody Consumption Growth Rate by Application (2014-2019) 7 Company Profiles and Key Figures in Stem Cell Antibody Business 7.1 Thermo Fisher Scientific, Inc. (U.S.) 7.1.1 Thermo Fisher Scientific, Inc. (U.S.) Stem Cell Antibody Production Sites and Area Served 7.1.2 Stem Cell Antibody Product Introduction, Application and Specification 7.1.3 Thermo Fisher Scientific, Inc. (U.S.) Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 7.1.4 Main Business and Markets Served 7.2 Merck Group (Germany), Abcam plc (U.K.) 7.2.1 Merck Group (Germany), Abcam plc (U.K.) Stem Cell Antibody Production Sites and Area Served 7.2.2 Stem Cell Antibody Product Introduction, Application and Specification 7.2.3 Merck Group (Germany), Abcam plc (U.K.) Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 7.2.4 Main Business and Markets Served 7.3 Becton, Dickinson and Company (U.S.) 7.3.1 Becton, Dickinson and Company (U.S.) Stem Cell Antibody Production Sites and Area Served 7.3.2 Stem Cell Antibody Product Introduction, Application and Specification 7.3.3 Becton, Dickinson and Company (U.S.) Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 7.3.4 Main Business and Markets Served 7.4 Bio-Rad Laboratories, Inc. (U.S.) 7.4.1 Bio-Rad Laboratories, Inc. (U.S.) Stem Cell Antibody Production Sites and Area Served 7.4.2 Stem Cell Antibody Product Introduction, Application and Specification 7.4.3 Bio-Rad Laboratories, Inc. (U.S.) Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 7.4.4 Main Business and Markets Served 7.5 Cell Signaling Technology, Inc. (U.S.) 7.5.1 Cell Signaling Technology, Inc. (U.S.) Stem Cell Antibody Production Sites and Area Served 7.5.2 Stem Cell Antibody Product Introduction, Application and Specification 7.5.3 Cell Signaling Technology, Inc. (U.S.) Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 7.5.4 Main Business and Markets Served 7.6 Agilent Technologies, Inc. (U.S.) 7.6.1 Agilent Technologies, Inc. (U.S.) Stem Cell Antibody Production Sites and Area Served 7.6.2 Stem Cell Antibody Product Introduction, Application and Specification 7.6.3 Agilent Technologies, Inc. (U.S.) Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 7.6.4 Main Business and Markets Served 7.7 F. Hoffmann-La Roche Ltd (Switzerland) 7.7.1 F. Hoffmann-La Roche Ltd (Switzerland) Stem Cell Antibody Production Sites and Area Served 7.7.2 Stem Cell Antibody Product Introduction, Application and Specification 7.7.3 F. Hoffmann-La Roche Ltd (Switzerland) Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 7.7.4 Main Business and Markets Served 7.8 Danaher Corporation (U.S.) 7.8.1 Danaher Corporation (U.S.) Stem Cell Antibody Production Sites and Area Served 7.8.2 Stem Cell Antibody Product Introduction, Application and Specification 7.8.3 Danaher Corporation (U.S.) Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 7.8.4 Main Business and Markets Served 7.9 GenScript (U.S.), PerkinElmer, Inc. (U.S.) 7.9.1 GenScript (U.S.), PerkinElmer, Inc. (U.S.) Stem Cell Antibody Production Sites and Area Served 7.9.2 Stem Cell Antibody Product Introduction, Application and Specification 7.9.3 GenScript (U.S.), PerkinElmer, Inc. (U.S.) Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 7.9.4 Main Business and Markets Served 7.10 Lonza (Switzerland), and BioLegend, Inc. (U.S.) 7.10.1 Lonza (Switzerland), and BioLegend, Inc. (U.S.) Stem Cell Antibody Production Sites and Area Served 7.10.2 Stem Cell Antibody Product Introduction, Application and Specification 7.10.3 Lonza (Switzerland), and BioLegend, Inc. (U.S.) Stem Cell Antibody Production, Revenue, Price and Gross Margin (2014-2019) 7.10.4 Main Business and Markets Served 8 Stem Cell Antibody Manufacturing Cost Analysis 8.1 Stem Cell Antibody Key Raw Materials Analysis 8.1.1 Key Raw Materials 8.1.2 Price Trend of Key Raw Materials 8.1.3 Key Suppliers of Raw Materials 8.2 Proportion of Manufacturing Cost Structure 8.3 Manufacturing Process Analysis of Stem Cell Antibody 8.4 Stem Cell Antibody Industrial Chain Analysis 9 Marketing Channel, Distributors and Customers 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.2 Stem Cell Antibody Distributors List 9.3 Stem Cell Antibody Customers 10 Market Dynamics 10.1 Market Trends 10.2 Opportunities 10.3 Market Drivers 10.4 Challenges 10.5 Influence Factors 11 Global Stem Cell Antibody Market Forecast 11.1 Global Stem Cell Antibody Production, Revenue Forecast 11.1.1 Global Stem Cell Antibody Production Growth Rate Forecast (2019-2025) 11.1.2 Global Stem Cell Antibody Revenue and Growth Rate Forecast (2019-2025) 11.1.3 Global Stem Cell Antibody Price and Trend Forecast (2019-2025) 11.2 Global Stem Cell Antibody Production Forecast by Regions (2019-2025) 11.2.1 North America Stem Cell Antibody Production, Revenue Forecast (2019-2025) 11.2.2 Europe Stem Cell Antibody Production, Revenue Forecast (2019-2025) 11.2.3 China Stem Cell Antibody Production, Revenue Forecast (2019-2025) 11.2.4 Japan Stem Cell Antibody Production, Revenue Forecast (2019-2025) 11.3 Global Stem Cell Antibody Consumption Forecast by Regions (2019-2025) 11.3.1 North America Stem Cell Antibody Consumption Forecast (2019-2025) 11.3.2 Europe Stem Cell Antibody Consumption Forecast (2019-2025) 11.3.3 China Stem Cell Antibody Consumption Forecast (2019-2025) 11.3.4 Japan Stem Cell Antibody Consumption Forecast (2019-2025) 11.4 Global Stem Cell Antibody Production, Revenue and Price Forecast by Type (2019-2025) 11.5 Global Stem Cell Antibody Consumption Forecast by Application (2019-2025) 12 Research Findings and Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.

View original post here:
Stem Cell Antibody Market Research Report: Probable Key Development To Be Observed Market States And Outlook Across By 2026 - Bulletin Line

Recent Research Could Restore Vision by Converting Skin Cells into Photoreceptors – Health Writeups

One of the most complex organs of the human anatomy is the eye. The eye controls the entire visual of an individual, with complex structures and components such as the retina. The retina is a complicated mix of cells and layers that help the eye focus and observe every detail in the field of eyesight.

Any infliction to the retina can result in severe outcomes, potentially leading to retinal diseases. Even the best medications currently like cell therapy can involve a lot of effort and time which the patients cannot give.

However, researchers at the North Texas Eye Research Institute looked into the matter and developed a fast and easier method to rebuild the damaged retina in eye diseases. The method involves a few chemicals that lead to the generation of cells which ultimately restore eyesight. Stem cell therapy

Macular degeneration is a typical reason for loss of eyesight in individuals aged over 60. In this case, the cells which sense light in the retina, primarily known as photoreceptors, begin to deteriorate. Traditionally, doctors have opted for medications for the last surgery to fix this. However, recently, researchers discovered stem cell therapy. This therapy is the method by which loss or degenerated cells are replaced with healthier cells. For the replenishment of these cells, researchers changed the type of specialized cells with the help of specific proteins known as Yamanaka factors.

Reprogramming of specialized cells

This is a big revolution in stem cell therapy. This method can reprogram or restore the generalization of specialized cells such as the heart and immune cells. Basic cells are called pluripotent stem cells. These cells possess the ability to further develop into several types of cells with the inclusion of photoreceptors that are lost in eye diseases.

However, there are rooms for improvements with the struggles in this method. The skin is usually a more typical origin for the reprogramming of cells. The usual time needed is 25 days for the conversion to stem cells. However, further conversion to photoreceptors might take 65-70 extra days, before they are ready to begin cell therapy.

Skipping the reprogramming

With 5 small chemicals, researchers at the North Texas Eye Research Institute have overcome these complications. After publishing their research, they explained that they used these chemicals called small molecule drugs which created photoreceptors straight from skin cells known as fibroblasts, and eliminated the reprogramming step altogether, with no involvement of stem cells.

The 5 chemicals were tested individually and as a combination. Results concluded that the combination showed the most promising results, transforming skin cells into cells that behaved like photoreceptors,

However, the similarity of the photoreceptor-like-cells and the actual photoreceptors, was studied. Hence, they studied the transcriptome of the two, which is an integral part of the cells identity. The results showed sufficient similarity. However, stem cell therapy is a very intricate process with a lot of complications.

The cells have to persist the transplant and change of environment while making the proper connections with the target cells for optimal functionality as a photoreceptor. The real experiment was to test the functionality of these chemically-generated photoreceptors in animal models of eye diseases.

Transplanting the chemically-generated photoreceptors

The transplant was performed in mice with retinal damage. Researchers concluded that almost half of the mice with retinal damage who received the transplant showed pupil reflexes which were similar to mice without retinal damage. This concluded visual response improvement.

The transplant also provided an improved vision, with better pupil reflexes. While these photoreceptors restored vision in the mice with retinal damage, it also helped researchers better understand the cells chemical machinery for the restoration of sight, which lays a foundation for different methods to improve vision.

Link:
Recent Research Could Restore Vision by Converting Skin Cells into Photoreceptors - Health Writeups

Escalating Demand for Novel Cell Sorting and Separation Amid COVID-19 to Record Sharp Growth through Pandemic – Medic Insider

The research study presented in this report offers complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the Global Novel Cell Sorting and Separation Market. The research study has been prepared with the use of in-depth qualitative and quantitative analyses of the global Novel Cell Sorting and Separation market. We have also provided absolute dollar opportunity and other types of market analysis on the global Novel Cell Sorting and Separation market.

It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global Novel Cell Sorting and Separation market. All findings and data on the global Novel Cell Sorting and Separation market provided in the report are calculated, gathered, and verified using advanced and reliable primary and secondary research sources. The regional analysis offered in the report will help you to identify key opportunities of the global Novel Cell Sorting and Separation market available in different regions and countries.

The report on the Novel Cell Sorting and Separation market provides a birds eye view of the current proceeding within the Novel Cell Sorting and Separation market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Novel Cell Sorting and Separation market and offers a clear assessment of the projected market fluctuations during the forecast period.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=2602287&source=atm

The authors of the report have segmented the global Novel Cell Sorting and Separation market as per product, application, and region. Segments of the global Novel Cell Sorting and Separation market are analyzed on the basis of market share, production, consumption, revenue, CAGR, market size, and more factors. The analysts have profiled leading players of the global Novel Cell Sorting and Separation market, keeping in view their recent developments, market share, sales, revenue, areas covered, product portfolios, and other aspects.

The key players covered in this study NanoCellect Biomedical Innovative Biochips Cesca Therapeutics Fluidigm LumaCyte Union Biometrica LevitasBio RareCyte Cytonome Namocell STEMCELL Technologies Akadeum Life Sciences QIAGEN ScreenCell

Market segment by Type, the product can be split into Cancer Cell Immune Cells Microbial Cell Red Blood Cell/Platelet Stem Cell Other Market segment by Application, split into Cell Research Biomedical Diagnosis Other

Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America

The study objectives of this report are: To analyze global Novel Cell Sorting and Separation status, future forecast, growth opportunity, key market and key players. To present the Novel Cell Sorting and Separation development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. To strategically profile the key players and comprehensively analyze their development plan and strategies. To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Novel Cell Sorting and Separation are as follows: History Year: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Year 2020 to 2026 For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.marketresearchhub.com/enquiry.php?type=E&repid=2602287&source=atm

Novel Cell Sorting and Separation Market Size and Forecast

In terms of region, this research report covers almost all the major regions across the globe such as North America, Europe, South America, the Middle East, and Africa and the Asia Pacific. Europe and North America regions are anticipated to show an upward growth in the years to come. While Novel Cell Sorting and Separation Market in Asia Pacific regions is likely to show remarkable growth during the forecasted period. Cutting edge technology and innovations are the most important traits of the North America region and thats the reason most of the time the US dominates the global markets. Novel Cell Sorting and Separation Market in South, America region is also expected to grow in near future.

The Novel Cell Sorting and Separation Market report highlights is as follows:

This Novel Cell Sorting and Separation market report provides complete market overview which offers the competitive market scenario among major players of the industry, proper understanding of the growth opportunities, and advanced business strategies used by the market in the current and forecast period.

This Novel Cell Sorting and Separation Market report will help a business or an individual to take appropriate business decision and sound actions to be taken after understanding the growth restraining factors, market risks, market situation, market estimation of the competitors.

The expected Novel Cell Sorting and Separation Market growth and development status can be understood in a better way through this five-year forecast information presented in this report

This Novel Cell Sorting and Separation Market research report aids as a broad guideline which provides in-depth insights and detailed analysis of several trade verticals.

You can Buy This Report from Here @ https://www.marketresearchhub.com/checkout?rep_id=2602287&licType=S&source=atm

Visit link:
Escalating Demand for Novel Cell Sorting and Separation Amid COVID-19 to Record Sharp Growth through Pandemic - Medic Insider